Dr. Patrick J. Boland, MD

Dr. Boland practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Boland's NPI, 1679552046, was assigned on January 12, 2006. Dr. Boland graduated from University College of Dublin National Univ SOM in 1967. Dr. Boland holds New York license 149458.

Dr. Boland's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Boland's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Boland to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boland practices, 3 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Boland's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Boland is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Boland's licenses on file in 3 states: New York, New Jersey and Pennsylvania.

Dmand AI lists joint cyst among the conditions Dr. Boland treats.

CMS data shows 15 Medicare services from Dr. Boland across 1 procedure code in 2024, all of them office visits, for 33 Medicare patients. Medicare paid $875 for them. Every service was in an office.

CMS counts 33 Medicare patients who saw Dr. Boland in 2024. The largest group is 65 to 74, with 16 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boland's median patient age at 67, with 55% women.

In 2021, Dr. Boland wrote 11 Medicare Part D claims. They cover 1 drug, with $218 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Boland for performance year 2024, reported as part of a group. Dr. Boland accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boland as offering telehealth.

Dmand AI links 81 papers to Dr. Boland, published from 2004 to 2023. 2019 was the busiest year, with 4. The most frequent topics are Bone Neoplasms, Spinal Neoplasms and Postoperative Complications. Dr. Boland has published most often in Clin Orthop Relat Res. Dr. Boland's most frequent co-authors are John H. Healey, MD, Mark H. Bilsky, MD and Edward A. Athanasian, MD.

CMS Open Payments shows 4 general payments to Dr. Boland from 4 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $125.

Dmand AI lists 1 award for Dr. Boland.

Dr. Boland graduated from University College of Dublin National Univ SOM in 1967. Dr. Boland is a member of ACS.

Dr. Boland is in network with 13 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.